Pamela Blair Allen, MD, MSc

• Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

  • Phase

    I
  • Conditions

    Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
  • Location

    Winship Cancer Institute

• AHOD2131

  • Phase

    III
  • Location

    Emory Proton Therapy Center, Winship Cancer Institute

• Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

  • Phase

    II
  • Conditions

    Angioimmunoblastic T-cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Follicular T-Cell Lymphoma, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Location

    Winship Cancer Institute, Grady Health System

• Nonconforming Lisocabtagene Maraleucel Expanded Access Protocol

  • Phase

    Expanded Access
  • Conditions

    Lymphoma, Large B-Cell, Diffuse
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• • Phase

    N/A
  • Location

    Winship Cancer Institute

Fifteen-Year Experience of a Single Institution: Outcomes for Early-Stage Hodgkins Lymphoma Comparing Chemotherapy Alone Versus Combined Modality Therapy.

Advances in radiation oncology

Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.

The Lancet. Oncology

ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.

Transplantation and cellular therapy

Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma.

Haematologica

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Blood advances

Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.

Blood advances

EBV-Positive Nodal T- and NK-Cell Lymphoma Mimicking Anaplastic Large Cell Lymphoma: A Case Report.

Hematology reports

Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.

The Lancet. Oncology

Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.

Blood advances

Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.

CNS oncology

Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study.

Clinical lymphoma, myeloma & leukemia

DMF in CTCL: where do we go from here?

Blood

Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.

Blood advances

Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.

Blood advances

Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial.

JAMA oncology

Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia.

Leukemia & lymphoma

Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.

Cancer

Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.

Cancer research communications

Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial.

Clinical lymphoma, myeloma & leukemia

Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary Syndrome.

JAMA dermatology

CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.

Clinical lymphoma, myeloma & leukemia

African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center.

Leukemia & lymphoma

Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.

Clinical lymphoma, myeloma & leukemia

Racial differences in clinical presentation and outcomes in mycosis fungoides and Sézary syndrome in the United States: a large singe center retrospective analysis.

European journal of cancer (Oxford, England : 1990)

T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma.

JAMA dermatology

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.

Blood

Supporting Decision-Making on Fertility Preservation Among Adolescent and Young Adult Women With Cancer.

Oncology (Williston Park, N.Y.)

Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy.

Clinical lymphoma, myeloma & leukemia

Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL).

Leukemia & lymphoma

Hepatosplenic T-cell lymphoma: a rare but challenging entity.

Blood

Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches.

Current oncology reports

A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma.

Leukemia & lymphoma

Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia.

Cancer

12/10/2024

This was my second appointment with her. Review applies to both visits. Amazing amount of time spent explaining a complicated set of conditions and possible concerns, treatments. Also referred to another specialist. Follow-up clear and concise

12/04/2024

Dr Allen was professional and very knowledgeable. Took time to thoroughly explain and answered our questions. We are beyond happy with her care

11/22/2024

Dr Allen communicated on my Level and answered MY QUESTIONS.

09/04/2024

Dr. Allen always takes time to let me get all my questions out.

08/23/2024

Dr. Allen was amazing.

08/08/2024

Very, very pleased with all stages of operation at your facility

05/08/2024

They talk fast and over your head. I only made through the the 11th grade. So you need to talk to me like i'm a teenager not a professor

04/01/2024

Dr. Allen provided excellent care & instruction and was able to get me BACK in the infusion skd.

01/19/2024

Loved Dr. Allen. Very knowledgeable and spent lots of time with us and answered all our questions that she could without further testing

09/13/2023

It was a thorough visit.

08/23/2023

Thank you Dr. Allen and Winship cancer center.

07/26/2023

My Doctor gives you her undivided attention and show complete concern when I ask questions.

06/03/2023

Dr Pamela Allen has been very clear and easy to talk with.

05/10/2023

Excellent!

02/24/2023

Dr Allen exuded a reassuring air of professionalism, compassion, and concern for my wellbeing. I left the appointment with all of my questions answered, and I feel very reassured that my treatment is in good hands with Dr Allen's team at Emory.

01/15/2023

I love doctor Allen. She is very caring and professional. Makes sure we understand what she is explaining to us. I chose to have her as my doctor instead of the first one I have. I live in Grovetown Georgia and we travel there if we have to. I agree with everyone that tells me Emory is the best and helped them.

01/11/2023

My visit with Dr. Allen was excellent...it's just that the news was not what I had hoped for.

01/08/2023

Very pleased with Dr. Allen